EUDA Signs Letter of Intent to Potentially Acquire GO POSB
1. EUDA signs LOI to acquire GO POSB, enhancing biotech capabilities. 2. GO POSB's iPSC technology opens new therapeutic and regenerative avenues. 3. A proposed facility in Shenzhen aims to distribute iPSC solutions. 4. The collaboration targets Asia's growing longevity and aesthetics markets. 5. EUDA aligns with A*STAR for advancing iPSC research and clinical trials.